Evidence map›Paper›PMID 37491756›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2023

Isoniazid-resistant TB: treatment outcomes and impact of regimens with fluoroquinolones.

D R Silva, M Muñoz-Torrico, G R Fernandes, L Narvaez-Diaz, A Miranda-Perez, A P C Dos Santos, E Becerril-Vargas, G Soto-Vidal, D M C Willers, G B Migliori

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Real-world treatment outcomes of a 6-month fluoroquinolone-containing regimen for isoniazid mono-resistant pulmonary tuberculosis in Korea.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

D R SilvaFaculdade de Medicina, and, Programa de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
M Muñoz-TorricoClínica de Tuberculosis.
G R FernandesPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS.
L Narvaez-DiazLaboratorio de Microbiologia Clínica, and.
A Miranda-PerezDirección de Enseñanza, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, México City, México.
A P C Dos SantosPrograma de Pós-Graduação em Ciências Pneumológicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
E Becerril-VargasLaboratorio de Microbiologia Clínica, and.
G Soto-VidalDirección de Enseñanza, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, México City, México.
D M C WillersHospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
G B MiglioriServizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico, Tradate, Italy.
Hospital de Clínicas de Porto Alegre · BRInstituto Nacional de Enfermedades Respiratorias · MXIstituti Clinici Scientifici Maugeri · ITUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsFluoroquinolonesHumansIsoniazidTreatment OutcomeAntitubercular AgentsFluoroquinolonesIsoniazid

Identifiers

PMID37491756
PMCPMC10365560
OpenAlexW4385263974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.